Despite Setbacks, Therapeutic Cancer Vaccine Trials March On

Dr. Gajewski has received research support for clinical trial participation from Bristol-Myers Squibb, GlaxoSmithKline-Bio, Incyte, Novartis, Eisai, and Genentech/Roche. He has served on advisory boards or served as a paid adviser to Bristol-Myers Squibb, GlaxoSmithKline-Bio, Incyte, Eisai, and Genentech/Roche. Dr. Sznol has received honoraria or served as a consultant to Bristol-Myers Squibb, Genzyme, and Pfizer.